UA112407C2 - AGOMELATIN CO-CRYSTALS, THE METHOD OF THEIR MANUFACTURING, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
AGOMELATIN CO-CRYSTALS, THE METHOD OF THEIR MANUFACTURING, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- UA112407C2 UA112407C2 UAA201206840A UAA201206840A UA112407C2 UA 112407 C2 UA112407 C2 UA 112407C2 UA A201206840 A UAA201206840 A UA A201206840A UA A201206840 A UAA201206840 A UA A201206840A UA 112407 C2 UA112407 C2 UA 112407C2
- Authority
- UA
- Ukraine
- Prior art keywords
- crystals
- agomelatin
- manufacturing
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Новий співкристал агомелатину, що складається з:агомелатину, або N-[2-(7-метокси-1-нафтил)етил]ацетаміду формули (І):, (I)таорганічної кислоти.Винахід стосуться також лікарських засобів, що містять співкристали агомелатину з органічними кислотами.A new agomelatine co-crystal consisting of: agomelatine or N- [2- (7-methoxy-1-naphthyl) ethyl] acetamide of formula (I) :, (I) inorganic acid. The invention also relates to medicines containing agomelatine co-crystals with organic acids.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1101766A FR2976284B1 (en) | 2011-06-09 | 2011-06-09 | NOVEL CO-CRYSTALS OF AGOMELATIN, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (1)
Publication Number | Publication Date |
---|---|
UA112407C2 true UA112407C2 (en) | 2016-09-12 |
Family
ID=46690337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201206840A UA112407C2 (en) | 2011-06-09 | 2012-06-05 | AGOMELATIN CO-CRYSTALS, THE METHOD OF THEIR MANUFACTURING, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN102816079B (en) |
AP (1) | AP3198A (en) |
CU (1) | CU20120086A7 (en) |
FR (1) | FR2976284B1 (en) |
HK (1) | HK1178881A1 (en) |
UA (1) | UA112407C2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2810647A1 (en) * | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
ES2645223T3 (en) * | 2013-06-06 | 2017-12-04 | Zentiva, K.S. | Agomelatine formulations comprising agomelatine in the form of co-crystals |
ES2959460T3 (en) * | 2015-03-31 | 2024-02-26 | Fis Fabbrica Italiana Sintetici Spa | solid form of agomelatine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE457089B (en) * | 1986-02-05 | 1988-11-28 | Sandvik Ab | PROVIDED TO TREAT A MIXTURE OF CARBON METAL BODIES TO Separate THESE FROM EACH OTHER ON THE BASIS OF THEIR COMPOSITIONS AND / OR STRUCTURES |
FR2866335B1 (en) * | 2004-02-13 | 2006-05-26 | Servier Lab | NEW PROCESS FOR THE SYNTHESIS OF AGOMELATIN |
EA200970806A1 (en) * | 2007-02-27 | 2010-08-30 | Вертекс Фармасьютикалз Инкорпорейтед | SOCRYSTALS AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS |
-
2011
- 2011-06-09 FR FR1101766A patent/FR2976284B1/en active Active
-
2012
- 2012-05-31 CU CU2012000086A patent/CU20120086A7/en unknown
- 2012-06-05 UA UAA201206840A patent/UA112407C2/en unknown
- 2012-06-11 CN CN201210191879.3A patent/CN102816079B/en not_active Expired - Fee Related
- 2012-06-11 AP AP2012006308A patent/AP3198A/en active
-
2013
- 2013-06-03 HK HK13106486.3A patent/HK1178881A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2976284B1 (en) | 2013-05-24 |
AP2012006308A0 (en) | 2012-06-30 |
CN102816079A (en) | 2012-12-12 |
CU20120086A7 (en) | 2014-01-29 |
HK1178881A1 (en) | 2013-09-19 |
FR2976284A1 (en) | 2012-12-14 |
CN102816079B (en) | 2015-04-08 |
AP3198A (en) | 2015-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201200728A1 (en) | NEW SOKRYSTALY AGOMELATIN, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
CY1120805T1 (en) | CRYSTAL FORMS SUSPENDER HYDROXYLASION PROYLO | |
ECSP13012668A (en) | 1-BENCILCICLOALQUILCARBOXÍLICOS ACIDS SUBSTITUTED AND ITS USE | |
EA201300388A1 (en) | COMPOUNDS OF SUBSTITUTED BENZAMIDE | |
EA201690520A1 (en) | METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES | |
CR20140554A (en) | DIMETIL-BENZOIC ACID COMPOUNDS | |
EA201391574A1 (en) | PHARMACEUTICALLY ACCEPTABLE N- [2- (7-METHOXI-1-NAPHYL) ETHYL] ACETAMIDE AND THE METHODS OF THEIR PRODUCTION | |
CL2011001405A1 (en) | Procedure for the preparation of n- [2- (7-methoxy-1-naphthyl) ethyl] acetamide, agomethalin. | |
EA201490152A1 (en) | TRPM8 ANTAGONISTS AND THEIR APPLICATION IN TREATMENT | |
BR112012014683A2 (en) | process for the production of 1-alkyl / 1-aryl-5-pyrazolecarboxylic acid derivatives | |
BR112014009760A2 (en) | sialic acid analogs, their use and pharmaceutical composition and sustained release pharmaceutical composition comprising them | |
UA112407C2 (en) | AGOMELATIN CO-CRYSTALS, THE METHOD OF THEIR MANUFACTURING, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MX360369B (en) | Fluoro-substituted (3r, 4r, 5s)-5-guanidino-4-acylamino-3-(pentan -3-yloxy) cyclohexene-1-carboxylic acids, esters thereof and a method for the use thereof. | |
CU20120087A7 (en) | HYDROCHLORIDE SYNTHESIS AND CRYSTAL FORM OF 4- (3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI) BENZAMIDE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
ES2403549R1 (en) | Agomelatine co-crystals with co-crystal formers | |
EA201400365A1 (en) | NEW THYRODUCT LACTS AS HIGHLY ACTIVE HDAC INHIBITORS AND THEIR APPLICATION AS MEDICINES | |
AR080150A1 (en) | USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF THE OBSESSIVE COMPULSIVE DISORDER (TOC) | |
FR2990134B1 (en) | PHARMACEUTICAL COMPOSITION OF PAPILLOMA VIRUS INHIBITOR | |
CR20130300A (en) | NEW AGOMELATINE SYNTHESIS PROCEDURE | |
MD20160072A2 (en) | Novel method for the synthesis of 7-methoxy-naphthalene-1-carbaldehyde and use thereof in the synthesis of agomelatine | |
TH1701003364A (en) | 3- (6-LcoxC-5-Chlorobenzo [D] isoxazole-3-Il) propanoic acid as useful as a monooxi kinurenene inhibitor. Genes | |
TH138902A (en) | A new type of co-crystalline agomelatine The processes for the preparation of such substances and the pharmaceutical components that contain them | |
UA109028C2 (en) | 2-HETARYL-2- (1,3-DIGIDRO-1-ISOBENZOFURANILIDEN) ACETONITRILES AND THE METHOD OF OBTAINING THEM | |
CR11459A (en) | A NEW PROCESS FOR SYNTHESIS AND THE NEW CRYSTAL FORMULA OF AGOMELATINE AND THE PHARMACEUTICAL COMPOUNDS THAT CONTAIN IT | |
UA110478C2 (en) | 3-methylaminosuccinoylamido-n-(3',4'-dimethylphenyl)anthranilic acid exhibiting high anti-inflammatory, analgetic, diuretic and antifungal activity |